Who We Are

Cytovation builds on over 15 years of cutting-edge research from two leading Norwegian institutions; University of Bergen and Haukeland University Hospital. Led by a highly experienced management team and world-renowned experts in tumour biology, an extensive research program has focused on engineering synthetic peptides with unique properties. CyPep-1, the company’s lead candidate, is being developed as a first-in-class lytic agent for the treatment of solid tumors.

Management Team

Kjell-Inge Arnevig

Chief Executive Officer

Serial entrepreneur with over 25 years of experience as managing director in global industrial enterprises.

Lars Prestegarden MD, PhD

Chief Medical Officer, Head of R&D

Associate professor of medicine with more than 15 years experience in cancer research.

Federico Grego

Chief Business Officer

20+ yrs of senior general management experience in specialty pharma (immunology & dermatology).

Raj Airey


25+ years experience in the pharma sector. Senior management roles in Pfizer and Baxter.

Ole-Erik Iversen, MD, PhD

Scientific Advisor

Professor Emeritus and University of Bergen. International KOL Cervical Cancer. Principal investigator HPV vaccines.

Eulalia Baselga, MD, PhD

Scientific Advisor

Professor of Dermatology U.A. Barcelona Head of Pediatric Dermatology 100+ publications.

Jian Wang, MD, PhD.

Scientific Advisor

Professor Cancer Biology, Qilu Hospital and Brain Science Research Institute Shandong University and University of Bergen.

Xavier Luria, MD

Regulatory Advisor

Founder and CEO Drug Development & Regulation (DDR). Former Head of Safety and Efficacy of Medicines, European Medicines Agency.

Board of Directors

Per Eystein Lønning, MD, PhD

Chairman & Founder

Professor of Oncology University of Bergen. Over 35 years of research experience with 300+ Publications.

Rolf Bjerkvig, PhD

Board Member & Founder

Professor of Cancer Biology University of Bergen. Director of Oncology in Luxembourg.

Stein Christian Mohn, MD, PhD

Board Member

Medical doctor with 15 years of senior executive management experience.

Egil Herman Sjursen

Board Member

Broad experience in finance and executive management. Previously CEO at Vesta, Nordea and Holberg.